Cite
MLA Citation
L. Tavera et al.. “BLU-945 or BLU-701 as single agents versus their combination with osimertinib in EGFR L858R driven tumor models.” European journal of cancer, vol. 174, n.d., pp. S63–. http://access.bl.uk/ark:/81055/vdc_100168600286.0x000030